BVT Aktienanleihe FRE 28.03.2025/ DE000VD1TW47 /
1/9/2025 8:42:00 AM | Chg.-0.06 | Bid4:51:42 PM | Ask4:51:42 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.92EUR | -0.06% | 101.98 Bid Size: 500,000 |
102.08 Ask Size: 500,000 |
FRESENIUS SE+CO.KGAA... | 27.00 - | 3/28/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil